MTF Biologics and Centurion Therapeutics to Expand Access to Wound Care Solutions

MTF Biologics and Centurion Therapeutics have negotiated a new agreement that will give more clinicians and patients in complex wound settings within hospitals and post-acute care facilities access to advanced wound healing technologies.

The agreement expands a five-year collaboration between MTF Biologics and Centurion, and grants Centurion exclusive distribution rights for a range of MTF Biologics’ tissue technologies, including placental, dermal, and adipose tissues. The tissue forms covered in the agreement include Amnioband Membrane, Salera Membrane, Salera Mini-Membrane, Allopatch Pliable, Allopatch Meshed, Somagen Meshed Dermal Matrix, and Leneva Adipose Matrix. The agreement also includes provisions for ongoing training, marketing, and support to ensure effective promotion and distribution of the tissue forms.  

“We are thrilled to announce this expanded partnership with Centurion Therapeutics,” MTF Biologics President/CEO Joe Yaccarino said. “Its team has proven their expertise over the past five years with us and demonstrated their reach within complex surgical wound care. The company is the ideal partner to help us deliver our tissue solutions to healthcare professionals and, ultimately, save and heal more lives. We have had a long and successful history with Centurion’s team in representing MTF Biologics’ technologies and look forward to our continued success.”  

Centurion Therapeutics will play a vital role in expanding the reach of MTF Biologics’ tissue forms to key customers, including surgical podiatrists, orthopedic surgeons, spine surgeons, vascular surgeons, OB/GYN surgeons, and general surgeons.  

“We are honored to collaborate with MTF Biologics to bring their tissue technologies to the forefront of medical practice,” Centurion Therapeutics President/CEO Robert Goodwin stated. “This partnership and expanded relationship represent a significant step forward in our mission to provide healthcare professionals with the tools they need to improve outcomes in patients suffering complex wounds.”  

Edison, N.J.-based MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. It provides service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists. The International Institute for the Advancement of Medicine (IIAM), a division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe. About Centurion Therapeutics 

Centurion Therapeutics is a distributor of medical products, dedicated to improving patient care through solutions and service. The company is base in Marshfield Hills, Mass.